Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer
Lung Cancer & Mesothelioma
-
-
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
-
Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)
-
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
-
Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
-
Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer
-
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
-
Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery
-
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202
-
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma
Categories
Alliance Committee
Browse by Year